1. Konzett H, Rothlin E (1953) Investigations on the hypotensive effect of the hydrogenated ergot alkaloids. Br J Clin Pharmacol 8: 201–207
2. Soergel F, Abisch E, Dennler HJ, Lang E (1984) Steady-state bioavailability of a new oral formulation of Hydergine in geriatric patients. Eur J Clin Pharmacol 26: 133–135
3. Bock KD, Welzel D, Dennler HJ (1982) Co-dergocrinmesylat bei älteren Hypertonikern. Münch Med Wochenschr 124: 1095–1098
4. Kroenig B, Dennler HJ (1984) Behandlung des älteren Hochdruckkranken mit Co-dergocrinmesylat. Therapiewoche 34: 4887–4900
5. Goldberg LI, Glock D, Kohli JD, Barnett A (1974) Separation of peripheral dopamine receptors by a selective DA1 antagonist. Hypertension 6 [Suppl 1] I-25–I-30